Key points from article :
Israeli company BioChange has developed a promising foam-based treatment, ReGum, to reverse gum recession by prompting gums to repair themselves. Successfully tested on dogs, the foam is now being marketed for veterinary use, with human trials and regulatory approval expected within two years. The product is a protein-based dental implant designed to regenerate complex periodontal tissue, including gums, bone, and ligaments that support teeth.
Gum recession, affecting 40% of adults, is often linked to chronic inflammation or poor dental habits. Current treatments like grafts, debridement surgery, or antibiotic implants are invasive and cumbersome. ReGum offers a potential breakthrough by enabling natural tissue regeneration without the need for extensive surgery. A peer-reviewed study by Dr. Ana Nemec confirmed its safety and effectiveness in animals, marking a first in achieving such results for periodontal tissue regeneration.
BioChange CEO Ishay Attar explained that the foam's unique 3D protein structure was developed over years of research and could also address recession caused by hard brushing. If successful in humans, ReGum could revolutionize how dentists treat gum disease, providing a simpler and more effective alternative to existing methods.
